{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:24:26Z","timestamp":1785414266665,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07173-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:06:49Z","timestamp":1751404009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic accuracy of urinary PENK methylation test for urothelial and other cancers: A prospective study"],"prefix":"10.1038","volume":"15","author":[{"given":"Sangmin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumjin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungyo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumsik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"7173_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"7173_CR2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman, J. D., Messer, J., Sielatycki, J. A. & Hollenbeak, C. S. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int. 107(7), 1059\u20131064 (2011).","journal-title":"BJU Int."},{"issue":"6","key":"7173_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis, V. et al. Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration. Cancer 115(6), 1224\u20131233 (2009).","journal-title":"Cancer"},{"issue":"1","key":"7173_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk, M. et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur. Urol. 81(1), 75\u201394 (2022).","journal-title":"Eur. Urol."},{"issue":"4","key":"7173_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1590\/S1677-5538.IBJU.2014.04.13","volume":"40","author":"A Greenstein","year":"2014","unstructured":"Greenstein, A., Greenstein, I., Senderovich, S. & Mabjeesh, N. J. Is diagnostic cystoscopy painful? Analysis of 1,320 consecutive procedures. Int. Braz. J. Urol. 40(4), 533\u2013538 (2014).","journal-title":"Int. Braz. J. Urol."},{"key":"7173_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.urology.2020.09.036","volume":"147","author":"J Linehan","year":"2021","unstructured":"Linehan, J., Schoenberg, M., Seltzer, E., Thacker, K. & Smith, A. B. Complications associated with ureteroscopic management of upper tract urothelial carcinoma. Urology 147, 87\u201395 (2021).","journal-title":"Urology"},{"issue":"2","key":"7173_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.urolonc.2014.06.008","volume":"33","author":"FA Yafi","year":"2015","unstructured":"Yafi, F. A. et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol. Oncol. 33(2), 66 (2015).","journal-title":"Urol. Oncol."},{"issue":"10","key":"7173_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas, M., Todenhofer, T. & Black, P. C. Urine biomarkers in bladder cancer - Current status and future perspectives. Nat. Rev. Urol. 20(10), 597\u2013614 (2023).","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"7173_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","volume":"39","author":"K Ng","year":"2021","unstructured":"Ng, K., Stenzl, A., Sharma, A. & Vasdev, N. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urol. Oncol. 39(1), 41\u201351 (2021).","journal-title":"Urol. Oncol."},{"issue":"11","key":"7173_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller, M. Epigenetics in cancer. N. Engl. J. Med. 358(11), 1148\u20131159 (2008).","journal-title":"N. Engl. J. Med."},{"key":"7173_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2022.10.015","volume":"178","author":"J Ibrahim","year":"2023","unstructured":"Ibrahim, J., Peeters, M., Van Camp, G. & Op de Beeck, K. Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives. Eur. J. Cancer. 178, 91\u2013113 (2023).","journal-title":"Eur. J. Cancer."},{"issue":"1","key":"7173_CR12","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1186\/s12885-022-10275-2","volume":"22","author":"TJ Oh","year":"2022","unstructured":"Oh, T. J. et al. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA. BMC Cancer 22(1), 1195 (2022).","journal-title":"BMC Cancer"},{"issue":"9","key":"7173_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jmoldx.2023.05.003","volume":"25","author":"TJ Oh","year":"2023","unstructured":"Oh, T. J. et al. Evaluation of sensitive urine DNA-based PENK methylation test for detecting bladder cancer in patients with hematuria. J. Mol. Diagn. 25(9), 646\u2013654 (2023).","journal-title":"J. Mol. Diagn."},{"issue":"7","key":"7173_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jmoldx.2024.04.001","volume":"26","author":"BR Bang","year":"2024","unstructured":"Bang, B. R. et al. EarlyTect BCD, a Streamlined PENK methylation test in urine DNA, effectively detects bladder cancer in patients with hematuria. J. Mol. Diagn. 26(7), 613\u2013623 (2024).","journal-title":"J. Mol. Diagn."},{"key":"7173_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1476-4598-7-62","volume":"7","author":"PP Anglim","year":"2008","unstructured":"Anglim, P. P. et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol. Cancer. 7, 62 (2008).","journal-title":"Mol. Cancer."},{"key":"7173_CR16","doi-asserted-by":"crossref","unstructured":"Jeong IG, Yun SC, Ha HK, Kang SG, Lee S, Park S, et al. Urinary DNA methylation test for bladder cancer diagnosis. JAMA Oncol. 2025.","DOI":"10.1001\/jamaoncol.2024.6160"},{"key":"7173_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-13-566","volume":"13","author":"JP Roperch","year":"2013","unstructured":"Roperch, J. P. et al. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. BMC Cancer 13, 566 (2013).","journal-title":"BMC Cancer"},{"issue":"5","key":"7173_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s13277-012-0378-3","volume":"33","author":"M Shitani","year":"2012","unstructured":"Shitani, M. et al. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Tumor. Biol. 33(5), 1307\u20131317 (2012).","journal-title":"Tumor. Biol."},{"issue":"12","key":"7173_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/pros.22833","volume":"74","author":"N Ashour","year":"2014","unstructured":"Ashour, N. et al. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis. Prostate 74(12), 1171\u20131182 (2014).","journal-title":"Prostate"},{"issue":"11","key":"7173_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1158\/1940-6207.CAPR-14-0179","volume":"8","author":"JP Foy","year":"2015","unstructured":"Foy, J. P. et al. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prev. Res. (Phila). 8(11), 1027\u20131035 (2015).","journal-title":"Cancer Prev. Res. (Phila)."},{"issue":"3","key":"7173_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cancers13030535","volume":"13","author":"AE Hentschel","year":"2021","unstructured":"Hentschel, A. E. et al. The origin of tumor DNA in urine of urogenital cancer patients: Local shedding and transrenal excretion. Cancers (Basel). 13(3), 535 (2021).","journal-title":"Cancers (Basel)."},{"issue":"59","key":"7173_CR22","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.18632\/oncotarget.22065","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. Evaluation of the NMP22 BladderChek test for detecting bladder cancer: A systematic review and meta-analysis. Oncotarget 8(59), 100648\u2013100656 (2017).","journal-title":"Oncotarget"},{"issue":"6","key":"7173_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.urolonc.2007.06.002","volume":"26","author":"T Hajdinjak","year":"2008","unstructured":"Hajdinjak, T. UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol. Oncol. 26(6), 646\u2013651 (2008).","journal-title":"Urol. Oncol."},{"issue":"6","key":"7173_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","volume":"4","author":"E Laukhtina","year":"2021","unstructured":"Laukhtina, E. et al. Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: A systematic review and network meta-analysis. Eur. Urol. Oncol. 4(6), 927\u2013942 (2021).","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"7173_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/JU.0000000000000786","volume":"204","author":"KEM van Kessel","year":"2020","unstructured":"van Kessel, K. E. M. et al. A urine based genomic assay to triage patients with hematuria for cystoscopy. J. Urol. 204(1), 50\u201357 (2020).","journal-title":"J. Urol."},{"issue":"6","key":"7173_CR26","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/JU.0000000000002135","volume":"206","author":"JD Raman","year":"2021","unstructured":"Raman, J. D. et al. The diagnostic performance of cxbladder resolve, alone and in combination with other cxbladder tests, in the identification and priority evaluation of patients at risk for urothelial carcinoma. J. Urol. 206(6), 1380\u20131389 (2021).","journal-title":"J. Urol."},{"issue":"26","key":"7173_CR27","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.7150\/jca.28192","volume":"10","author":"N Zhang","year":"2019","unstructured":"Zhang, N. et al. Identification of cancer-specific methylation of gene combination for the diagnosis of bladder cancer. J. Cancer. 10(26), 6761\u20136766 (2019).","journal-title":"J. Cancer."},{"issue":"6","key":"7173_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","volume":"68","author":"JP Sfakianos","year":"2015","unstructured":"Sfakianos, J. P. et al. Genomic characterization of upper tract urothelial carcinoma. Eur. Urol. 68(6), 970\u2013977 (2015).","journal-title":"Eur. Urol."},{"issue":"13","key":"7173_CR29","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","volume":"23","author":"JW Catto","year":"2005","unstructured":"Catto, J. W. et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J. Clin. Oncol. 23(13), 2903\u20132910 (2005).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"7173_CR30","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cancers14061520","volume":"14","author":"L Bialek","year":"2022","unstructured":"Bialek, L. et al. Non-invasive biomarkers in the diagnosis of upper urinary tract urothelial carcinoma-A systematic review. Cancers (Basel). 14(6), 1520 (2022).","journal-title":"Cancers (Basel)."},{"issue":"6","key":"7173_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","volume":"209","author":"JA Coleman","year":"2023","unstructured":"Coleman, J. A. et al. Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO guideline. J. Urol. 209(6), 1071\u20131081 (2023).","journal-title":"J. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07173-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07173-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07173-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:06:50Z","timestamp":1751404010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07173-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7173"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07173-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles outlined in the Declaration of Helsinki and approved by the Institutional Review Board of Asan Medical Center, Seoul, Korea (IRB number: 2022\u20130704). Written informed consent was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"22149"}}